Quantitation of unbound sunitinib and its metaboliteN-desethyl sunitinib (SU12662) in human plasma by equilibrium dialysis and liquid chromatography-tandem mass spectrometry: application to a pharmacokinetic study-Reference-Cited by-同舟云学术

Quantitation of unbound sunitinib and its metaboliteN-desethyl sunitinib (SU12662) in human plasma by equilibrium dialysis and liquid chromatography-tandem mass spectrometry: application to a pharmacokinetic study

Published:2012-01-18 Issue:11 Volume:26 Page:1315-1324
ISSN:0269-3879
Container-title:Biomedical Chromatography
language:en
Short-container-title:Biomed. Chromatogr.

Author:

Rais Rana¹,Zhao Ming¹,He Ping¹,Xu Linping¹,Deeken John F.²,Rudek Michelle A.¹

Affiliation:

1. The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins; Baltimore; MD; 21231; USA

2. Lombardi Cancer Center; Georgetown University Medical Center; Washington; DC; 20007; USA

Publisher

Wiley

Subject

Clinical Biochemistry,Drug Discovery,Pharmacology,Molecular Biology,General Medicine,Biochemistry,Analytical Chemistry

Reference21 articles.

1. Role of tyrosine kinase inhibitors in cancer therapy;Arora;Journal of Pharmacology and Experimental Therapeutics,2005

2. Sunitinib malate for the treatment of metastatic renal cell carcinoma and gastrointestinal stromal tumors;Adams;Clinical Therapeutics,2007

3. Sunitinib maleate;Atkins;Nature Review Drug Discovery,2006

4. Equilibrium dialysis, ultrafiltration, and ultracentrifugation compared for determining the plasma-protein-binding characteristics of valproic acid;Barre;Clinical Chemistry,1985

5. Measurement of fraction unbound paclitaxel in human plasma;Brouwer;Drug Metabolism and Disposition,2000

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Quantification of levetiracetam in plasma and urine and its application to a pharmacokinetic study of traumatic brain injury patients;Bioanalysis;2023-01

2. Analysis of sunitinib malate, a multi-targeted tyrosine kinase inhibitor: A critical review;Microchemical Journal;2021-04

3. EGFR inhibitors switch keratinocytes from a proliferative to a differentiative phenotype affecting epidermal development and barrier function;BMC Cancer;2021-01-05

4. Therapeutic Drug Monitoring of Sunitinib in Gastrointestinal Stromal Tumors and Metastatic Renal Cell Carcinoma in Adults—A Review;Therapeutic Drug Monitoring;2020-02

5. A new high-performance liquid chromatography–tandem mass spectrometry method for the determination of sunitinib and N-desethyl sunitinib in human plasma: Light-induced isomerism overtaking towards therapeutic drug monitoring in clinical routine;Journal of Pharmaceutical and Biomedical Analysis;2020-02